Funding Sources

Sponsor | % of overall organisation’s income

Novartis | 34%

Roche | 25%

Uniqure | 12%

Wave Life Science | 10%

PTC Therapeutics | 4%

Huntington’s Disease Society of America (HDSA) | 6%

European Federation of Neurological Associations (EFNA) | 3%

Associaciao Portuguese dos Doentes de Huntington | 6%